13F HOLDINGS REPORT
Deep Track Capital, LP
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001856083-25-000001
Total Value
$2.68B
Positions
63
Other Managers
0
Confidential Omitted
No
Holdings (63)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 17,791,486 | $227.2M | 8.47% |
| 2 | GUARDANT HEALTH INC | GH | 6,419,566 | $196.1M | 7.31% |
| 3 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 2,000,000 | $167.0M | 6.23% |
| 4 | IMMUNOVANT INC | IMVT | 6,000,000 | $148.6M | 5.54% |
| 5 | APELLIS PHARMACEUTICALS INC | APLS | 4,274,921 | $136.4M | 5.09% |
| 6 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 3,460,756 | $125.0M | 4.66% |
| 7 | CYTOKINETICS INC | CYTK | 2,500,000 | $117.6M | 4.39% |
| 8 | OCULAR THERAPEUTIX INC | OCUL | 12,836,282 | $109.6M | 4.09% |
| 9 | VIRIDIAN THERAPEUTICS INC | VRDN | 4,522,741 | $86.7M | 3.23% |
| 10 | PLIANT THERAPEUTICS INC | PLRX | 5,972,257 | $78.7M | 2.93% |
| 11 | STRUCTURE THERAPEUTICS INC | GPCR | 2,800,000 | $75.9M | 2.83% |
| 12 | IONIS PHARMACEUTICALS INC | IONS | 1,933,928 | $67.6M | 2.52% |
| 13 | NURIX THERAPEUTICS INC | NRIX | 3,000,000 | $56.5M | 2.11% |
| 14 | MBX BIOSCIENCES INC | MBX | 3,018,935 | $55.6M | 2.08% |
| 15 | 89BIO INC | 282559103 | 6,478,249 | $50.7M | 1.89% |
| 16 | HARMONY BIOSCIENCES HLDGS IN | HRMY | 1,450,000 | $49.9M | 1.86% |
| 17 | DYNE THERAPEUTICS INC | DYN | 2,000,000 | $47.1M | 1.76% |
| 18 | SEPTERNA INC | SEPN | 1,912,929 | $43.8M | 1.63% |
| 19 | NEUMORA THERAPEUTICS INC. | NMRA | 4,000,000 | $42.4M | 1.58% |
| 20 | GENMAB A/S | GNMSF | 2,000,000 | $41.7M | 1.56% |
| 21 | AKERO THERAPEUTICS INC | 00973Y108 | 1,490,000 | $41.5M | 1.55% |
| 22 | VERONA PHARMA PLC | 925050106 | 850,000 | $39.5M | 1.47% |
| 23 | CELLDEX THERAPEUTICS INC NEW | CLDX | 1,540,132 | $38.9M | 1.45% |
| 24 | PROTAGONIST THERAPEUTICS INC | PTGX | 1,000,000 | $38.6M | 1.44% |
| 25 | ANI PHARMACEUTICALS INC | ANIP | 649,042 | $35.9M | 1.34% |
| 26 | BICARA THERAPEUTICS INC | BCAX | 2,000,000 | $34.8M | 1.30% |
| 27 | AUTOLUS THERAPEUTICS PLC | AUTL | 14,218,903 | $33.4M | 1.25% |
| 28 | KORRO BIO INC | KRRO | 874,614 | $33.3M | 1.24% |
| 29 | TERNS PHARMACEUTICALS INC | TERN | 5,576,558 | $30.9M | 1.15% |
| 30 | ENGENE HOLDINGS INC | ENGNW | 4,557,575 | $30.3M | 1.13% |
| 31 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 653,513 | $27.5M | 1.03% |
| 32 | ABIVAX SA | AAVXF | 3,579,209 | $26.2M | 0.98% |
| 33 | CENTESSA PHARMACEUTICALS PLC | CNTA | 1,350,000 | $22.6M | 0.84% |
| 34 | BRIDGEBIO PHARMA INC | BBIO | 819,162 | $22.5M | 0.84% |
| 35 | GALAPAGOS NV | GLPGF | 780,778 | $21.5M | 0.80% |
| 36 | OLEMA PHARMACEUTICALS INC | OLMA | 3,442,833 | $20.1M | 0.75% |
| 37 | MIND MEDICINE MINDMED INC | 60255C885 | 2,816,594 | $19.6M | 0.73% |
| 38 | EDGEWISE THERAPEUTICS INC | EWTX | 710,421 | $19.0M | 0.71% |
| 39 | BICYCLE THERAPEUTICS PLC | BCYC | 1,276,081 | $17.9M | 0.67% |
| 40 | UPSTREAM BIO INC | UPB | 1,000,000 | $16.4M | 0.61% |
| 41 | NOVAVAX INC | NVAX | 2,000,000 | $16.1M | 0.60% |
| 42 | IMMUNOCORE HLDGS PLC | IMCR | 519,376 | $15.3M | 0.57% |
| 43 | ORUKA THERAPEUTICS INC | ORKA | 750,000 | $14.5M | 0.54% |
| 44 | GERON CORP | GERN | 4,011,287 | $14.2M | 0.53% |
| 45 | CYBIN INC | HELP | 1,529,987 | $13.5M | 0.50% |
| 46 | NEUMORA THERAPEUTICS INC. | NMRA | 1,189,800 | $12.6M | 0.47% |
| 47 | XENCOR INC | XNCR | 500,000 | $11.5M | 0.43% |
| 48 | ALIGOS THERAPEUTICS INC | ALGS | 244,110 | $9.7M | 0.36% |
| 49 | RAPT THERAPEUTICS INC | 75382E109 | 6,011,380 | $9.5M | 0.35% |
| 50 | ZURA BIO LTD | ZURA | 3,283,783 | $8.2M | 0.31% |
| 51 | CONTEXT THERAPEUTICS INC | CNTX | 7,419,355 | $7.8M | 0.29% |
| 52 | ALLAKOS INC | 01671P100 | 5,704,282 | $6.9M | 0.26% |
| 53 | XENON PHARMACEUTICALS INC | XENE | 169,132 | $6.6M | 0.25% |
| 54 | AVALO THERAPEUTICS INC | AVTX | 867,000 | $6.4M | 0.24% |
| 55 | INOVIO PHARMACEUTICALS INC | INO | 3,119,162 | $5.7M | 0.21% |
| 56 | REGULUS THERAPEUTICS INC | 75915K309 | 3,262,564 | $5.2M | 0.19% |
| 57 | SPYRE THERAPEUTICS INC | SYRE | 219,015 | $5.1M | 0.19% |
| 58 | INVIVYD INC | IVVD | 10,689,603 | $4.7M | 0.18% |
| 59 | ONKURE THERAPEUTICS INC | OKUR | 523,989 | $4.5M | 0.17% |
| 60 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 609,900 | $3.4M | 0.13% |
| 61 | CLIMB BIO INC | CLYM | 1,040,115 | $1.9M | 0.07% |
| 62 | NEKTAR THERAPEUTICS | NKTR | 1,975,998 | $1.8M | 0.07% |
| 63 | CASSAVA SCIENCES INC | 14817C107 | 500,000 | $1.2M | 0.04% |